| Protocol ID: | 113809 |
| Clinical Study ID: | 113809 |
| Official Title: | Immunological non-inferiority between two process-manufactured influenza vaccines in adults aged 18 to 60 years |
| Phase: | Phase 3 |
| Study Indications or Diseases: |
|
| Generic Name: | H1N1 Pandemic Influenza Vaccine |
| Trade/Product Name: | Pandemrix |
| Approved Drug Label: | http://www.gsk.com/products/prescription-medicines/index.htm |
| Results Summary: |
Click here to download result summary. |
| Citations: |
|